{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:13:22Z","timestamp":1793402002554,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003662","name":"Korea Evaluation Institute of Industrial Technology","doi-asserted-by":"publisher","award":["KEIT 20018560"],"award-info":[{"award-number":["KEIT 20018560"]}],"id":[{"id":"10.13039\/501100003662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003662","name":"Korea Evaluation Institute of Industrial Technology","doi-asserted-by":"publisher","award":["NTIS 2410012708"],"award-info":[{"award-number":["NTIS 2410012708"]}],"id":[{"id":"10.13039\/501100003662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00350161"],"award-info":[{"award-number":["RS-2024-00350161"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jconrel.2026.114953","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:31:47Z","timestamp":1777271507000},"page":"114953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Intestinal microenvironment-modulating nanomedicines for inflammatory bowel disease"],"prefix":"10.1016","volume":"395","author":[{"given":"Jaehyun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namjo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongrok","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaiwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jconrel.2026.114953_bb0005","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1021\/acs.molpharmaceut.2c00222","article-title":"Emerging nanotechnologies and microbiome engineering for the treatment of inflammatory bowel disease","volume":"19","author":"Abed","year":"2022","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0010","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1038\/s41598-022-11819-z","article-title":"Characterizing the mucin-degrading capacity of the human gut microbiota","volume":"12","author":"Glover","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114953_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41575-018-0079-5","article-title":"Control and dysregulation of redox signalling in the gastrointestinal tract","volume":"16","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41575-025-01129-w","article-title":"Proteases in intestinal health and disease","volume":"23","author":"Deraison","year":"2026","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114953_bb0030","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41578-022-00426-z","article-title":"Design of therapeutic biomaterials to control inflammation","volume":"7","author":"Tu","year":"2022","journal-title":"Nat. Rev. Mater."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114953_bb0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114953_bb0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","article-title":"Macrophages in intestinal homeostasis and inflammatory bowel disease","volume":"20","author":"Hegarty","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114953_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41575-023-00871-3","article-title":"Neutrophils: from IBD to the gut microbiota","volume":"21","author":"Danne","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114953_bb0050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2023.11.304","article-title":"Dysbiosis and associated stool features improve prediction of response to biological therapy in inflammatory bowel disease","volume":"166","author":"Caenepeel","year":"2024","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.jconrel.2026.114953_bb0055","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41579-024-01075-5","article-title":"The oral-gut microbiome axis in health and disease","volume":"22","author":"Kunath","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114953_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.molmed.2023.01.001","article-title":"IBD disease-modifying therapies: insights from emerging therapeutics","volume":"29","author":"Kotla","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114953_bb0065","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/ars.2020.8018","article-title":"The dual role of reactive oxygen species-generating nicotinamide adenine dinucleotide phosphate oxidases in gastrointestinal inflammation and therapeutic perspectives","volume":"33","author":"Dang","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jconrel.2026.114953_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1390351","article-title":"The emerging role of oxidative stress in inflammatory bowel disease","volume":"15","author":"Muro","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0075","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1038\/s41467-025-58513-y","article-title":"Self-disassembling nanoparticles as oral nanotherapeutics targeting intestinal microenvironment","volume":"16","author":"Park","year":"2025","journal-title":"Nat. Commun."},{"issue":"28","key":"10.1016\/j.jconrel.2026.114953_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn1745","article-title":"Orally administrated liquid metal agents for inflammation-targeted alleviation of inflammatory bowel diseases","volume":"10","author":"Liu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114953_bb0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.actbio.2023.02.026","article-title":"ROS scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease","volume":"161","author":"Bao","year":"2023","journal-title":"Acta Biomater."},{"issue":"17","key":"10.1016\/j.jconrel.2026.114953_bb0090","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1021\/acsami.1c25180","article-title":"Polycatechol-derived mesoporous polydopamine nanoparticles for combined ROS scavenging and gene interference therapy in inflammatory bowel disease","volume":"14","author":"Wang","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.114953_bb0095","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jconrel.2024.11.065","article-title":"A ROS-responsive hydrogel that targets inflamed mucosa to relieve ulcerative colitis by reversing intestinal mucosal barrier loss","volume":"377","author":"Wang","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202411979","article-title":"Reactive oxygen species triggered cleavage of thioketal-containing supramolecular nanoparticles for inflammation-targeted oral therapy in ulcerative colitis","volume":"35","author":"Xiong","year":"2025","journal-title":"Adv. Funct. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114953_bb0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.ymthe.2023.02.017","article-title":"Reactive oxygen species-responsive nanocarrier ameliorates murine colitis by intervening colonic innate and adaptive immune responses","volume":"31","author":"Yan","year":"2023","journal-title":"Mol. Ther."},{"issue":"19","key":"10.1016\/j.jconrel.2026.114953_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309972","article-title":"A gas therapy strategy for intestinal flora regulation and colitis treatment by nanogel-based multistage NO delivery microcapsules","volume":"36","author":"Fu","year":"2024","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.jconrel.2026.114953_bb0115","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","article-title":"Mucus barrier, mucins and gut microbiota: the expected slimy partners?","volume":"69","author":"Paone","year":"2020","journal-title":"Gut"},{"issue":"300","key":"10.1016\/j.jconrel.2026.114953_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa5657","article-title":"An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"36","key":"10.1016\/j.jconrel.2026.114953_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202301585","article-title":"Efficient therapy of inflammatory bowel disease with highly specific and durable targeted Ta\u2082C modified with chondroitin sulfate (TACS)","volume":"35","author":"Song","year":"2023","journal-title":"Adv. Mater."},{"issue":"45","key":"10.1016\/j.jconrel.2026.114953_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202004692","article-title":"An orally administered CeO\u2082@montmorillonite nanozyme targets inflammation for inflammatory bowel disease therapy","volume":"30","author":"Zhao","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"18","key":"10.1016\/j.jconrel.2026.114953_bb0135","doi-asserted-by":"crossref","first-page":"17287","DOI":"10.1021\/acsnano.4c14373","article-title":"Reactive oxygen species-responsive polymer drug delivery system targeted oxidative stressed colon cells to ameliorate colitis","volume":"19","author":"Cai","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114953_bb0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114953_bb0145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.actbio.2021.12.015","article-title":"Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease","volume":"140","author":"Shrestha","year":"2022","journal-title":"Acta Biomater."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114953_bb0150","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41551-024-01224-4","article-title":"Reinforcement of the intestinal mucosal barrier via mucus-penetrating PEGylated bacteria","volume":"8","author":"Chen","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114953_bb0155","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41575-025-01092-6","article-title":"Intestinal pH: a major driver of human gut microbiota composition and metabolism","volume":"22","author":"Brinck","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2026.114953_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114101","article-title":"Advances in the treatment of inflammatory bowel disease: focus on polysaccharide nanoparticulate drug delivery systems","volume":"181","author":"Hadji","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"33","key":"10.1016\/j.jconrel.2026.114953_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202311890","article-title":"Colon targeting pH-responsive coacervate microdroplets for treatment of ulcerative colitis","volume":"20","author":"Tian","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114953_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120347","article-title":"Application of inulin\/Eudragit RS in 5-ASA pellet coating with tuned, sustained-release feature in an animal model of ulcerative colitis","volume":"597","author":"Shahdadi Sardou","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114953_bb0175","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2147\/IJN.S291090","article-title":"Dual functional eudragit\u00ae S100\/L30D-55 and PLGA colon-targeted nanoparticles of iridoidglycoside for improved treatment of induced ulcerative colitis","volume":"16","author":"Gao","year":"2021","journal-title":"Int. J. Nanomedicine"},{"issue":"37","key":"10.1016\/j.jconrel.2026.114953_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp9882","article-title":"Oral zero-valent-molybdenum nanodots for inflammatory bowel disease therapy","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci. Adv."},{"issue":"16","key":"10.1016\/j.jconrel.2026.114953_bb0185","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1021\/acs.nanolett.3c02128","article-title":"PH-mediated mucus penetration of zwitterionic polydopamine-modified silica nanoparticles","volume":"23","author":"Ma","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114953_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jare.2020.03.007","article-title":"Possible synergy effect of hydrogen sulfide and acetate produced by sulfate-reducing bacteria on inflammatory bowel disease development","volume":"27","author":"Kushkevych","year":"2020","journal-title":"J. Adv. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114953_bb0195","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3390\/antiox11112235","article-title":"Hydrogen sulfide metabolizing enzymes in the intestinal mucosa in pediatric and adult inflammatory bowel disease","volume":"11","author":"Stummer","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0200","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1021\/acsami.4c17782","article-title":"An oral H\u2082S-responsive cu\u2085.\u2084O nanozyme platform with strong ROS\/H\u2082S scavenging capacity for the treatment of colitis","volume":"17","author":"Ma","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.114953_bb0205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2024.07.071","article-title":"Modified montmorillonite armed probiotics with enhanced on-site mucus-depleted intestinal colonization and H\u2082S scavenging for colitis treatment","volume":"374","author":"Yang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114953_bb0210","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.actbio.2024.07.054","article-title":"Matrix metalloproteinase-responsive hydrogels with tunable retention for on-demand therapy of inflammatory bowel disease","volume":"186","author":"Xie","year":"2024","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0215","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2219427","article-title":"Responsive nanosystems for targeted therapy of ulcerative colitis: current practices and future perspectives","volume":"30","author":"Chen","year":"2023","journal-title":"Drug Deliv."},{"issue":"14","key":"10.1016\/j.jconrel.2026.114953_bb0220","article-title":"Orally administrable H\u2082S-scavenging metal-organic framework prepared by co-flow microfluidics for comprehensive restoration of intestinal milieu","volume":"35","author":"Dou","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114953_bb0225","article-title":"Synergistic hemostasis and inflammation resolution for reversing IBD: a macrophage-based enzyme-responsive liposomal strategy","volume":"525","author":"Zhang","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"19","key":"10.1016\/j.jconrel.2026.114953_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300069","article-title":"Advanced nanomedicine: redefining therapeutic paradigms for inflammatory bowel disease","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0235","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1038\/s41467-025-63037-6","article-title":"Targeting intestinal inflammation using locked nucleic acids delivered via lipid nanoparticles","volume":"16","author":"Qassem","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114953_bb0240","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.apsb.2022.03.025","article-title":"A polyphenol-assisted IL-10 mRNA delivery system for ulcerative colitis","volume":"12","author":"Chen","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114953_bb0245","first-page":"138","article-title":"Oral TNF-\u03b1 siRNA delivery via milk-derived exosomes for effective treatment of inflammatory bowel disease","volume":"34","author":"Han","year":"2024","journal-title":"Bioact. Mater."},{"issue":"14","key":"10.1016\/j.jconrel.2026.114953_bb0250","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.7150\/thno.97139","article-title":"Engineered plant-derived extracellular vesicles for targeted regulation and treatment of colitis-associated inflammation","volume":"14","author":"Kang","year":"2024","journal-title":"Theranostics"},{"issue":"42","key":"10.1016\/j.jconrel.2026.114953_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/advs.72372","article-title":"MicroRNA-enriched plant-derived exosomes alleviate colitis by modulating systemic immunity, metabolic homeostasis, and gut microbiota","volume":"12","author":"Shi","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0260","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1186\/s12951-024-02861-2","article-title":"Mannose-coated selenium nanoparticles normalize intestinal homeostasis and mitigate colitis by inhibiting NF-\u03baB activation and enhancing glutathione peroxidase expression","volume":"22","author":"Yang","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0265","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12951-022-01598-0","article-title":"Two-birds-one-stone colon-targeted nanomedicine treats ulcerative colitis via remodeling immune microenvironment and anti-fibrosis","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114953_bb0270","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic cell migration in inflammation and immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.114953_bb0275","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.immuni.2024.09.011","article-title":"Antigen-presenting cells as specialized drivers of intestinal t cell functions","volume":"57","author":"Kedmi","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0280","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2045046","article-title":"Gut commensal limosilactobacillus reuteri induces atypical memory-like phenotype in human dendritic cells in vitro","volume":"14","author":"Lasaviciute","year":"2022","journal-title":"Gut Microbes"},{"issue":"11","key":"10.1016\/j.jconrel.2026.114953_bb0285","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41423-024-01218-x","article-title":"Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed t cells","volume":"21","author":"Ohara","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.114953_bb0290","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jare.2024.04.023","article-title":"Tolerogenic dendritic cell-mediated regulatory t cell differentiation by Chinese herbal formulation attenuates colitis progression","volume":"70","author":"Huang","year":"2025","journal-title":"J. Adv. Res."},{"issue":"35","key":"10.1016\/j.jconrel.2026.114953_bb0295","doi-asserted-by":"crossref","first-page":"49335","DOI":"10.1021\/acsami.5c13156","article-title":"Orally delivered tolerogenic nanotherapeutic for targeted colitis therapy via ROS scavenging and Treg\/Th17 modulation","volume":"17","author":"Min","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114953_bb0300","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41590-022-01268-1","article-title":"The function of Wtap in n6-adenosine methylation of mRNAs controls t cell receptor signaling and survival of t cells","volume":"23","author":"Ito-Kureha","year":"2022","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114953_bb0305","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory t cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0310","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106265","article-title":"Mesenchymal stem cell-derived extracellular vesicles with high PD-L1 expression for autoimmune diseases treatment","volume":"34","author":"Xu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114953_bb0315","article-title":"ROS-responsive nanoparticles for oral delivery of luteolin and targeted therapy of ulcerative colitis by regulating pathological microenvironment","volume":"14","author":"Tan","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0320","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41467-024-46025-0","article-title":"Targeted delivery of fc-fused PD-L1 for effective management of acute and chronic colitis","volume":"15","author":"Tang","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0325","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40580-024-00414-9","article-title":"Polymeric DNase-I nanozymes targeting neutrophil extracellular traps for the treatment of bowel inflammation","volume":"11","author":"Wang","year":"2024","journal-title":"Nano Converg."},{"key":"10.1016\/j.jconrel.2026.114953_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102139","article-title":"Platelet-inspired nanomedicine targeting activated neutrophils to alleviate ulcerative colitis by free radical scavenging and controlled neutrophil swarming","volume":"54","author":"Yan","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.114953_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2024.04.001","article-title":"Ginger exosome-like nanoparticle-derived miRNA therapeutics: a strategic inhibitor of intestinal inflammation","volume":"69","author":"Yan","year":"2025","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0340","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12951-022-01421-w","article-title":"Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114953_bb0345","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.omtn.2022.09.018","article-title":"Deficiency of miRNA-149-3p shaped gut microbiota and enhanced dextran sulfate sodium-induced colitis","volume":"30","author":"Feng","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"32","key":"10.1016\/j.jconrel.2026.114953_bb0350","doi-asserted-by":"crossref","first-page":"20886","DOI":"10.1021\/acsnano.4c05013","article-title":"Advanced bioinspired multifunctional platforms focusing on gut microbiota regulation","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114953_bb0355","series-title":"Bioinformatic and Statistical Analysis of Microbiome Data","author":"Xia","year":"2023"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0360","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40168-023-01530-0","article-title":"Kernel-based genetic association analysis for microbiome phenotypes identifies host genetic drivers of beta-diversity","volume":"11","author":"Liu","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.jconrel.2026.114953_bb0365","article-title":"The interplay between the microbiota, diet and t regulatory cells in the preservation of the gut barrier in inflammatory bowel disease","volume":"14","author":"Kumar","year":"2023","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114953_bb0370","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3390\/pathogens11070781","article-title":"Gut microbiota composition associated with clostridioides difficile colonization and infection","volume":"11","author":"Martinez","year":"2022","journal-title":"Pathogens"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114953_bb0375","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3390\/microorganisms12071341","article-title":"Effect of probiotic bacteria on the gut microbiome of mice with lipopolysaccharide-induced inflammation","volume":"12","author":"Gryaznova","year":"2024","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114953_bb0380","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41565-023-01346-x","article-title":"Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis","volume":"18","author":"Cao","year":"2023","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41522-025-00663-4","article-title":"Bifidobacterium longum NSP001-derived extracellular vesicles ameliorate ulcerative colitis by modulating t cell responses in gut microbiota-(in)dependent manners","volume":"11","author":"Nie","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114953_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207890","article-title":"Probiotic-inspired nanomedicine restores intestinal homeostasis in colitis by regulating redox balance, immune responses, and the gut microbiome","volume":"35","author":"Xu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114953_bb0395","doi-asserted-by":"crossref","first-page":"0062","DOI":"10.34133\/bmr.0062","article-title":"Combining gut microbiota modulation and enzymatic-triggered colonic delivery by prebiotic nanoparticles improves mouse colitis therapy","volume":"28","author":"Li","year":"2024","journal-title":"Biomater. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0400","doi-asserted-by":"crossref","first-page":"10893","DOI":"10.1038\/s41467-024-55263-1","article-title":"Colon-targeted engineered postbiotics nanoparticles alleviate osteoporosis through the gut-bone axis","volume":"15","author":"Yu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114953_bb0405","article-title":"Oral nanoparticle therapy for inflammatory bowel disease by Paneth cell regulation and mucus layer remodeling","volume":"8","author":"Qin","year":"2025","journal-title":"Cell Mater."},{"issue":"26","key":"10.1016\/j.jconrel.2026.114953_bb0410","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado6798","article-title":"Oral microsphere formulation of m2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis","volume":"10","author":"Luo","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114953_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113755","article-title":"Precisely edited gut microbiota by tungsten-doped Prussian blue nanoparticles for the treatment of inflammatory bowel disease","volume":"382","author":"Luo","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114953_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2025.100098","article-title":"Chemical exchange saturation transfer MRI trackable peptide hydrogel for drug release monitoring and targeted therapy in inflammatory bowel disease","volume":"1","author":"Li","year":"2025","journal-title":"Cell Biomater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0425","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1038\/s41467-021-27463-6","article-title":"Nanoparticle-assembled bioadhesive coacervate coating with prolonged gastrointestinal retention for inflammatory bowel disease therapy","volume":"12","author":"Zhao","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0430","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41563-019-0462-9","article-title":"Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis","volume":"19","author":"Lee","year":"2020","journal-title":"Nat. Mater."},{"issue":"21","key":"10.1016\/j.jconrel.2026.114953_bb0435","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf3887","article-title":"Oral polyphenol-armored nanomedicine for targeted modulation of gut microbiota-brain interactions in colitis","volume":"9","author":"He","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0440","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1021\/acsnano.2c11188","article-title":"Synthetic lignin-derived therapeutic nano reagent as intestinal pH-sensitive drug carriers capable of bypassing the gastric acid environment for colitis treatment","volume":"17","author":"Zhao","year":"2023","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114953_bb0445","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1021\/acsnano.3c11496","article-title":"Metabolic nanoregulator remodels gut microenvironment for treatment of inflammatory bowel disease","volume":"18","author":"Xu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114953_bb0450","article-title":"Enteric-coated cerium dioxide nanoparticles for effective inflammatory bowel disease treatment by regulating the redox balance and gut microbiome","volume":"14","author":"Huang","year":"2025","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.jconrel.2026.114953_bb0455","doi-asserted-by":"crossref","first-page":"21116","DOI":"10.1021\/acsnano.3c04819","article-title":"An orally-administered nanotherapeutics with carbon monoxide supplying for inflammatory bowel disease therapy by scavenging oxidative stress and restoring gut immune homeostasis","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114953_bb0460","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41575-020-0293-9","article-title":"Head-to-head trials in inflammatory bowel disease: past, present and future","volume":"17","author":"Pouillon","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114953_bb0465","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrgastro.2016.208","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.114953_bb0470","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/gutjnl-2019-320022","article-title":"25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future","volume":"70","author":"D\u2019Haens","year":"2021","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.jconrel.2026.114953_bb0475","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41575-023-00768-1","article-title":"IL-12 and IL-23 pathway inhibition in inflammatory bowel disease","volume":"20","author":"Verstockt","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114953_bb0480","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/ecco-jcc\/jjad100","article-title":"Efficacy and safety of advanced oral small molecules for inflammatory bowel disease: systematic review and meta-analysis","volume":"17","author":"Solitano","year":"2023","journal-title":"J. Crohns Colitis"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114953_bb0485","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","article-title":"JAK-STAT pathway targeting for the treatment of inflammatory bowel disease","volume":"17","author":"Salas","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0490","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/gutjnl-2023-330000","article-title":"Rise of precision medicine: can it deliver on its promise in IBD?","volume":"75","author":"Schreiber","year":"2025","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jconrel.2026.114953_bb0495","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/ijms26020575","article-title":"Advancing inflammatory bowel disease treatment by targeting the innate immune system and precision drug delivery","volume":"26","author":"Kiilerich","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114953_bb0500","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/pharmaceutics17020226","article-title":"PH-dependent drug delivery systems for ulcerative colitis treatment","volume":"17","author":"Gvozdeva","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0505","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12967-023-04326-w","article-title":"A precise molecular subtyping of ulcerative colitis reveals the immune heterogeneity and predicts clinical drug responses","volume":"21","author":"Mo","year":"2023","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114953_bb0510","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-022-00604-y","article-title":"Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?","volume":"19","author":"Villablanca","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"25","key":"10.1016\/j.jconrel.2026.114953_bb0515","first-page":"00263","article-title":"Ulcerative colitis: moving beyond the mucosal dogma","volume":"S2468-1253","author":"Eggermont","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2026.114953_bb0520","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj2372","article-title":"A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease","volume":"8","author":"Shi","year":"2022","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0525","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5217\/ir.2019.09160","article-title":"Efficacy and safety of vedolizumab in Crohn's disease in patients from Asian countries in the GEMINI 2 study","volume":"19","author":"Banerjee","year":"2021","journal-title":"Intest. Res."},{"key":"10.1016\/j.jconrel.2026.114953_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicines most popular component, poly(ethylene) glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114953_bb0535","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","article-title":"Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114953_bb0540","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.3390\/pharmaceutics15112600","article-title":"Delivery strategies of probiotics from nano- and microparticles: trends in the treatment of inflammatory bowel disease\u2014an overview","volume":"15","author":"Lopes","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114953_bb0545","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apt.16148","article-title":"Systematic review: the global incidence of Faecal microbiota transplantation-related adverse events from 2000 to 2020","volume":"53","author":"Marcella","year":"2021","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:57:36Z","timestamp":1783162656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":109,"alternative-id":["S0168365926003561"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114953","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intestinal microenvironment-modulating nanomedicines for inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114953"}}